Veterans’ Assuring Critical Care Expansions to Support Servicemembers (ACCESS) Act of 2025

The Veterans' ACCESS Act (S.275) was introduced January 28, 2025 by Sen. Moran (R-KS) and reported favorably out of the Senate Veterans' Affairs Committee on July 30, 2025, where it currently awaits floor action. A companion bill (HR740) has been ordered reported in the House. The bill's core mechanism is codifying into statute the eligibility standards for the Veterans Community Care Program (VCCP), which determines when veterans can elect to receive care from private providers instead of VA facilities. The bill also requires the VA to notify veterans of their VCCP eligibility within two business days and extends the submission deadline for provider claims to 180 days — both operational changes that reduce friction for providers treating veterans. The money trail is indirect but structurally significant. The bill authorizes zero direct spending, meaning no taxpayer dollars are obligated by the bill itself. Instead, the revenue impact flows entirely through utilization-driven increases in existing VCCP reimbursement. The Congressional Budget Office (CBO) would score this as increasing direct spending if it projects higher VA community care enrollment, but the actual dollar impact will depend on uptake rates post-passage. This is typical for eligibility-expansion bills — the policy signal for investors is stronger than any near-term revenue number. Structural winners are healthcare REITs $VTR, $WELL, and $SBRA, whose medical office buildings, outpatient facilities, and skilled nursing properties house the private sector providers that VCCP patients will visit. These REITs benefit regardless of which specific hospital system or physician group sees the patient — the need for physical space drives their demand. Hospital operators $HCA and $UHS also benefit from incremental patient volume, but the signal is muddier. HCA's recent 30-day decline of -8.2% and UHS's -5.59% decline reflect broader market headwinds in hospital stocks unrelated to this bill. The policy tailwind from S.275 provides a partial offset. Real price data shows healthcare REITs already pricing in this expansion. Over the last 30 days, $VTR gained +7.25%, $WELL +8.63%, and $SBRA +6.08%, each approaching or hitting 52-week highs. HCA and UHS declined significantly over the same period — HCA dropped from ~$488 to $434.44, and UHS from ~$182 to $168.96 — suggesting that market concerns about hospital reimbursement more broadly are dominating any positive signal from this bill for those tickers. Timeline: The bill is stuck at the stage awaiting Senate floor action. With 14 cosponsors and bipartisan support (Sen. Moran is a Republican), floor passage is likely if scheduled, but the Senate calendar is competitive. The House companion bill adds momentum. Full enactment could occur within 1-2 months if leadership prioritizes it, or could slip into the next session if competitors like broader VA reform bills absorb floor time.